Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 217,804,352
  • Shares Outstanding, K 5,960,710
  • Annual Sales, $ 52,824 M
  • Annual Income, $ 7,215 M
  • 36-Month Beta 1.01
  • Price/Sales 4.23
  • Price/Cash Flow 10.81
  • Price/Book 3.56

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.95 +1.64%
on 12/26/17
37.35 -2.17%
on 12/18/17
-0.04 (-0.11%)
since 12/12/17
3-Month
34.10 +7.14%
on 10/31/17
37.35 -2.17%
on 12/18/17
+0.19 (+0.52%)
since 10/12/17
52-Week
30.90 +18.25%
on 01/24/17
37.35 -2.17%
on 12/18/17
+3.94 (+12.09%)
since 01/12/17

Most Recent Stories

More News
Glaxo's Influenza Vaccine Gets FDA Nod for Label Expansion

Glaxo's (GSK) influenza vaccine ??? Fluarix Quadrivalent receives FDA approval for label expansion.

NVS : 86.65 (+1.14%)
EXEL : 30.38 (+1.00%)
PFE : 36.54 (-0.05%)
GSK : 37.50 (+1.79%)
Ligand (LGND) Inks Deal With Glenmark for OmniAb Platform

Ligand (LGND) enters into a worldwide license agreement with Glenmark for OmniAb platform.

LGND : 148.90 (+0.64%)
MRK : 58.66 (+1.84%)
NVS : 86.65 (+1.14%)
PFE : 36.54 (-0.05%)
Dow 30 Stock Roundup: Boeing Q4 Deliveries Up Y/Y, Success for Merck's Keytruda Combo

The Dow endured a volatile week during which the index hit a fresh record high.

AAPL : 177.09 (+1.03%)
SNP : 84.07 (+2.14%)
KO : 46.15 (+0.24%)
CVX : 133.60 (+0.78%)
JPM : 112.67 (+1.65%)
JNJ : 145.76 (+0.67%)
MRK : 58.66 (+1.84%)
LLY : 86.98 (+0.68%)
GS : 257.03 (+0.74%)
PFE : 36.54 (-0.05%)
BA : 336.21 (+2.47%)
Merck's Keytruda on a Roll: Can it Retain the Spark in 2018?

Merck's (MRK) Keytruda rapidly grows as its key top-line driver. The Keytruda development program shows significant advancement in 2017.

MRK : 58.66 (+1.84%)
LLY : 86.98 (+0.68%)
AMGN : 185.04 (+1.69%)
PFE : 36.54 (-0.05%)
Pharma Stock Roundup: Novo Nordisk Reveals Bid to Acquire Ablynx, Pfizer & Others at Healthcare Conference

Focus this week was on pipeline updates provided by several companies including Pfizer (PFE) at a healthcare conference while Novo Nordisk's bid to acquire Ablynx also made news.

NVO : 55.04 (+0.15%)
JNJ : 145.76 (+0.67%)
MRK : 58.66 (+1.84%)
PFE : 36.54 (-0.05%)
GSK : 37.50 (+1.79%)
SNY : 44.78 (+1.75%)
BMY : 62.81 (+0.54%)
Parkinson's Disease Space Again Under Spotlight This Week

Parkinson's Disease emerges a lucrative area in want of curative therapies in the space. To this end, many players work toward launching new treatments in the market.

ADMS : 35.58 (-0.08%)
NVS : 86.65 (+1.14%)
TEVA : 22.07 (+1.52%)
PFE : 36.54 (-0.05%)
Key Takeaways from Pfizer & 3 Other Drug Stocks at Healthcare Conference

Here is a look at key takeaways from presentations made by four major pharma and biotech stocks including Pfizer (PFE) at the annual J.P. Morgan healthcare conference.

CELG : 106.00 (+1.36%)
MRK : 58.66 (+1.84%)
PFE : 36.54 (-0.05%)
BMY : 62.81 (+0.54%)
5 ETFs to Bet on 2018 Dogs of the Dow

We have highlighted five ETFs with heavy exposure to the Dogs of the Dow that look exciting for 2018.

CSCO : 40.87 (+1.92%)
VZ : 51.86 (-0.48%)
KO : 46.15 (+0.24%)
CVX : 133.60 (+0.78%)
MRK : 58.66 (+1.84%)
PFE : 36.54 (-0.05%)
SDOG : 48.12 (+0.54%)
FDL : 30.61 (+0.23%)
IBM : 163.14 (-0.65%)
CAT : 170.30 (+0.65%)
XOM : 87.52 (+0.68%)
PG : 89.61 (-0.60%)
DOD : 24.29 (-0.86%)
HDV : 91.20 (+0.31%)
GE : 18.76 (-1.37%)
BA : 336.21 (+2.47%)
DJD : 35.34 (+0.91%)
Merck's Keytruda Combo Gets Breakthrough Therapy Status

Merck's (MRK) Keytruda in combination with Eisai's Lenvima gets breakthrough therapy designation from the FDA as a potential treatment for advanced kidney cancer.

MRK : 58.66 (+1.84%)
NVS : 86.65 (+1.14%)
AMGN : 185.04 (+1.69%)
PFE : 36.54 (-0.05%)
5 ETFs to Bet on 2018 Dogs of the Dow

We have highlighted five ETFs with heavy exposure to the Dogs of the Dow that look exciting for 2018.

CSCO : 40.87 (+1.92%)
VZ : 51.86 (-0.48%)
KO : 46.15 (+0.24%)
CVX : 133.60 (+0.78%)
MRK : 58.66 (+1.84%)
PFE : 36.54 (-0.05%)
SDOG : 48.12 (+0.54%)
FDL : 30.61 (+0.23%)
IBM : 163.14 (-0.65%)
CAT : 170.30 (+0.65%)
XOM : 87.52 (+0.68%)
PG : 89.61 (-0.60%)
DOD : 24.29 (-0.86%)
HDV : 91.20 (+0.31%)
GE : 18.76 (-1.37%)
BA : 336.21 (+2.47%)
DJD : 35.34 (+0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional...

See More

Key Turning Points

2nd Resistance Point 36.94
1st Resistance Point 36.74
Last Price 36.54
1st Support Level 36.40
2nd Support Level 36.26

See More

52-Week High 37.35
Last Price 36.54
Fibonacci 61.8% 34.89
Fibonacci 50% 34.13
Fibonacci 38.2% 33.36
52-Week Low 30.90

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.